Boehringer Ingelheim Austria - Value through Innovation

Working with Purpose: better health for humans and animals.

We are working towards a more sustainable and better future for the next generation. Our commitment to sustainable development is firmly embedded in our corporate culture - has been for more than 130 years. We aim to drive innovation, create new value in areas of high unmet medical need, and change lives for the better by engaging with society and communities.

Mental Health

Schizophrenia in real life: Stories of challenges, resilience and hope

Schizophrenia affects approximately 24 million people worldwide. That’s 24 million individual stories and 24 million lives impacted – and that still doesn’t include the countless experiences of the families and carers of those living with this serious mental illness.

Innovation

New cancer research building: Boosting innovation in oncology

A new building now provides more space and the latest technologies to get closer to our goal of curing cancer. It underpins our long-lasting commitment to partnerships and collaborations.

Explore our News & Stories

Who we are

Vision & Values

Day by day, more than 52,000 employees of Boehringer Ingelheim create value through innovation with a clear goal: to provide more health and improve the lives of both humans and animals.

Animal Health

Companion Animals

Everything we do is based on innovation. Our goal is to offer advanced, preventive animal health and to develop smart and effective solutions for those who raise and care for animals.

Social Responsibility

Solidarity with Ukraine

Our company condemns military aggression against Ukraine and provides long-term support to people in need through monetary and in-kind donations.

Boehringer Ingelheim

What began in 1885 with 28 employees has evolved over time into a global company with three business units: Human Pharma, Animal Health and Biopharmaceutical Contract Manufacturing.